Deep learning-based volumetry of the future liver remnants and prediction of candidates for major hepatectomy
To develop and validate a deep learning-based future liver remnant (FLR) volumetry system (DL-FLRVS) by secondary utilization of existing preoperative CT images, and to compare the differences between the currently used method and DL-FLRVS in volumetry of FLR and the application in candidate categorization before major hepatectomy. DL-FLRVS, which consists of five 3D U-Net models for the automated segmentation of liver anatomy on contrast-enhanced CT, was developed (n = 307, 170, 170, 170, and 492, respectively) and validated (n = 178) in external validation cohorts. The FLR and FLR% of patients were measured using DL-FLRVS and the hepatic VCAR (i.e., a semi-automated segmentation program on a dedicated workstation) for different types of major hepatectomy. Manual measurements were used as a reference. The differences in FLR assessment and candidate categorization between the two methods were compared using Spearman analysis and McNemar’s test, respectively. The mean FLR and FLR% values were (493.51 ± 284.77) cm3 and (38.53 ± 19.38) %, respectively, when DL-FLRVS was used, (489.23 ± 286.29) cm3 and (37.77 ± 19.12) %, when the hepatic VCAR was used. No significant differences in the categorization of candidates for major hepatectomy were found between the DL-FLRVS and human doctors (P > 0.99 and P > 0.99, respectively) or between the hepatic VCAR and human doctors (P > 0.99 and P = 0.07, respectively). DL-FLRVS represents a potential alternative to the currently used method in volumetry of FLR and FLR-based candidate categorization in major hepatectomy in clinical practice.
Authors
- Tingting Xie (ORCID: https://orcid.org/0000-0003-1125-9547)
- Kun Ma (ORCID: https://orcid.org/0000-0002-9649-5073)
- E Tuya
- Taomei Zhu (ORCID: https://orcid.org/0000-0003-3036-3446)
- Zichun Hua (ORCID: https://orcid.org/0000-0001-7962-0402)
- Demin Xu
- Yongbin Li (ORCID: https://orcid.org/0009-0003-9224-9937)
- Huiming Shan (ORCID: https://orcid.org/0000-0003-4900-7003)
- Guanxun Cheng (ORCID: https://orcid.org/0000-0001-9168-1670)
- Ziwei Liu (ORCID: https://orcid.org/0000-0003-1785-2966)
- Zhengwei Li (ORCID: https://orcid.org/0000-0003-1644-1006)
- Jingyu Zhou
- Yaofeng Zhang (ORCID: https://orcid.org/0009-0006-0822-6356)
- Xiaoying Wang
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Peking University (CN)
- National Cancer Center (US)
- Key Laboratory of Guangdong Province (CN)
- BOE Technology Group (China) (CN)
- Guangdong Academy of Sciences (CN)
- Peking University Shenzhen Hospital (CN)
- Peking University First Hospital (CN)
- Guangdong Academy of Medical Sciences (CN)
- Department of Health of Guangdong Province (CN)
- Guangdong Provincial People's Hospital (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- BMC Medical Imaging
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1186/s12880-025-02106-0
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00